Skip to content

RANDOMIZED DISSECTION OF AXILLAR DISEASE VS NON-DISSECTION AXILAR FOR PATIENTS WITH BREAST CANCER AND CLINICALLY NEGATIVE GANGLIA WITH MICROMETASTASIS IN THE CENTINELA GANGLIO.

RANDOMIZED DISSECTION OF AXILLAR DISEASE VS NON-DISSECTION AXILAR FOR PATIENTS WITH BREAST CANCER AND CLINICALLY NEGATIVE GANGLIA WITH MICROMETASTASIS IN THE CENTINELA GANGLIO.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REPEC
Registry ID
PER-078-03
Enrollment
Unknown
Registered
2004-01-22
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

axillary dissection Type of group
For patients in whom axillary dissection is indicated (nodule macrometastatic sentinel or randomized micrometastatic sentinel node for axillary dissection) should be complete, including at least 2 levels defined by Breg, The conservation of the pectoralis minor muscle depends on the surgeons criteria.

Sponsors

INTERNATIONAL BREAST CANCER STUDY GROUP - IBCSG,
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Any age. Clinical, mammographic, uitrasonographic, or pathological diagnosis of breast carcinoma. A prior biopsy of the primary tumor is allowed, but the laminae and tumor block must be sent to the Coordination Center of the IBCSG for the Central of Pathological Review. No previous systematic therapy for breast cancer.

Exclusion criteria

Exclusion criteria: Patients with clinical evidence of distant metastasis. Any suspicious manifestation requires an appropriate investigation to exclude metastasis. Palpable axillary lymph node (s). Paget´s disease without invasive cancer. Paget´s disease with invasive cancer is allowed. Pregnancy or lactation.

Design outcomes

Primary

MeasureTime frame
Outcome name:not contemplated Measure:not contemplated Timepoints:not contemplated

Secondary

MeasureTime frame
Outcome name:not contemplated Measure:not contemplated Timepoints:not contemplated

Countries

Peru

Outcome results

None listed

Source: REPEC (via WHO ICTRP)